Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:INOV

Inovalon (INOV) Stock Price, News & Analysis

Inovalon logo

About Inovalon Stock (NASDAQ:INOV)

Advanced Chart

Key Stats

Today's Range
$30.03
$30.07
50-Day Range
$40.66
$41.06
52-Week Range
$17.56
$41.06
Volume
8,970 shs
Average Volume
720,587 shs
Market Capitalization
$4.66 billion
P/E Ratio
88.33
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.

Receive INOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inovalon and its competitors with MarketBeat's FREE daily newsletter.

INOV Stock News Headlines

Longtime Inovalon CEO Keith Dunleavy to retire
$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
Inovalon Announces CEO Transition
See More Headlines

INOV Stock Analysis - Frequently Asked Questions

Inovalon Holdings, Inc. (NASDAQ:INOV) announced its quarterly earnings data on Wednesday, July, 28th. The technology company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.02. The technology company earned $190.44 million during the quarter, compared to analyst estimates of $183.89 million. Inovalon had a net margin of 6.73% and a trailing twelve-month return on equity of 10.97%.

Inovalon (INOV) raised $500 million in an IPO on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Inovalon's top institutional shareholders include Raymond James Financial Inc. (0.06%), Raymond James Financial Inc. (0.06%), WPWealth LLP (0.04%) and Citadel Advisors LLC (0.01%).
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inovalon investors own include NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), Moderna (MRNA), Meta Platforms (META) and PayPal (PYPL).

Company Calendar

Last Earnings
7/28/2021
Today
2/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Data Processing & Preparation
Sub-Industry
N/A
Current Symbol
NASDAQ:INOV
Employees
1,836
Year Founded
N/A

Profitability

Net Income
$22.58 million
Pretax Margin
5.86%

Debt

Sales & Book Value

Annual Sales
$667.52 million
Cash Flow
$0.90 per share
Book Value
$4.94 per share

Miscellaneous

Free Float
78,011,000
Market Cap
$4.66 billion
Optionable
No Data
Beta
0.53

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:INOV) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners